Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1OLANZAPINE

02 1ONDANSETRON

03 2RISPERIDONE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Health 2.0 Conference
Not Confirmed
arrow
Health 2.0 Conference
Not Confirmed

OLANZAPINE

Drug : OLANZAPINE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 203708

Country : US

Patented : No

blank

02

arrow
Health 2.0 Conference
Not Confirmed
arrow
Health 2.0 Conference
Not Confirmed

ONDANSETRON

Drug : ONDANSETRON

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78050

Country : US

Patented : No

blank

03

arrow
Health 2.0 Conference
Not Confirmed
arrow
Health 2.0 Conference
Not Confirmed

RISPERIDONE

Drug : RISPERIDONE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 77328

Country : US

Patented : No

blank

04

arrow
Health 2.0 Conference
Not Confirmed
arrow
Health 2.0 Conference
Not Confirmed

RISPERIDONE

Drug : RISPERIDONE

Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

Application Number : 78464

Country : US

Patented : No

blank